Business Wire

MUNICH--(BUSINESS WIRE)-- Isarna Therapeutics today announced upcoming oral presentations at the OIS Retina Innovation Summit on May 4th and the Association for Research in Vision and Ophthalmology (ARVO) Meeting on May 7th, both in Seattle, WA. Isarna’s Chief Medical Officer, Prof. Marion R. Munk, will present updated clinical data from its Phase 2 BETTER study evaluating the company’s lead program, ISTH0036.

ISTH0036 is an RNA-based antisense molecule that... (continue reading...)

FRANKFURT, Germany--(BUSINESS WIRE)-- Accenture (NYSE: ACN) has agreed to acquire Parsionate, a data consultancy specialized in data products and modern data foundation services, ranging from data strategy development to technology implementation.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240430329877/en/

Accenture has agreed to acquire Parsionate, a data consultancy specialized in data products and... (continue reading...)

SACRAMENTO, Calif.--(BUSINESS WIRE)-- Momentum, an award-winning clean-tech consulting firm dedicated to accelerating clean energy projects, is proud to announce the launch of their latest innovation: "Agency Landscape Updates." This biweekly email subscription is designed to empower organizations by providing concise, public funding information across key states and federal opportunities. Topic areas include Grid Resilience, Zero-Emission Transportation, and... (continue reading...)

AWS customers worldwide can now deploy Proofpoint’s full stack of people and information protection that defend organizations’ human layer

SUNNYVALE, Calif.--(BUSINESS WIRE)-- Proofpoint, Inc., a leading cybersecurity and compliance company, today announced the availability of its award-winning human-centric security solutions in AWS Marketplace, a digital catalog with thousands of software listings from independent software vendors that make it easy to find,... (continue reading...)

• EfficAPSI is a real-world study with the largest number of patients follow-up to date in the field of allergen immunotherapy (AIT).1
• The rigorous methodology used in this study provides important insights about Stallergenes Greer SLIT-liquid as allergic asthma disease-modifying medicine. 1
• In this study, treatment with Stallergenes Greer SLIT-liquid was associated with a one-third reduction in the incidence of new asthma events in patients, with or without a... (continue reading...)